Ultragenyx Pharmaceutical RARE
NASDAQ RARE
$15.14 -0.18 (-1.21%)
As of: Sep 30, 2026 · 1:37 PM EDT

Ultragenyx Pharmaceutical Inc. (RARE) EPS (Diluted) (2017 - 2026)

Updated

Ultragenyx Pharmaceutical's EPS (Diluted) was -$0.90 in Q2 2026, compared with -$1.17 a year earlier.

Analysis

Ultragenyx Pharmaceutical Inc. (RARE) EPS (Diluted) (2017 - 2026) Analysis & Trends

On a trailing twelve-month basis, Ultragenyx Pharmaceutical's EPS (Diluted) was -$5.75 through Jun 30, 2026; for FY2025, it was -$5.83.

  • In earlier years, EPS (Diluted) was -$6.28 in FY2024, -$8.25 in FY2023, -$10.12 in FY2022 and -$6.70 in FY2021.
  • The Q2 2026 figure marks the highest quarterly EPS (Diluted) since Q4 2020.
  • Per Business Quant data, RARE's EPS (Diluted) in the three quarters before Q2 2026 was -$1.84 (Q1 2026), -$1.30 (Q4 2025) and -$1.81 (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.90
Mar 31, 2026 -1.84
Dec 31, 2025 -1.30
Sep 30, 2025 -1.81
Jun 30, 2025 -1.17
Mar 31, 2025 -1.57
Dec 31, 2024 -1.47
Sep 30, 2024 -1.40
Jun 30, 2024 -1.52
Mar 31, 2024 -2.03
Dec 31, 2023 -1.68
Sep 30, 2023 -2.23
Jun 30, 2023 -2.25
Mar 31, 2023 -2.33
Dec 31, 2022 -2.17
Sep 30, 2022 -3.50
Jun 30, 2022 -2.26
Mar 31, 2022 -2.19
Dec 31, 2021 -1.81
Sep 30, 2021 -1.08
API Access

Ultragenyx Pharmaceutical Inc. EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=RARE&period=max&api_key=YOUR_API_KEY